It has been reported that activation of SIRT1 suppressed AT1R expression and enhanced NO bioavailability, thereby ameliorating hypertension in mice (Miyazaki et al. 2008; Cui et al. 2012). The gene discussed is SIRT1; the disease is hypertensive disorder.